Stay updated with breaking news from Vivos Method. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First Medicare-Accepted Oral Appliance Treatment for All Severities of Obstructive Sleep Apnea in Adults LITTLETON, Colo., April 9, 2024 - Vivos Therapeutics,...
Vivos' CARE oral devices for sleep apnea are now eligible for Medicare reimbursement, broadening treatment alternatives for beneficiaries.
Vivos reported positive business momentum following receiving FDA clearance for its oral appliances to treat severe OSA last November.
LITTLETON, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device...
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 14,000 shares, a decrease of 84.0% from the December 31st total of 87,300 shares. Based on an average daily volume of 998,700 shares, […]